ProAssurance Corp
PRA
View Detailed Chart
23.819USD
+0.029+0.12%
Market hours （ET）Quotes delayed by 15 min
1.22BMarket Cap
25.14P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.12%
5 Days
+0.50%
1 Month
-0.30%
6 Months
+51.62%
Year to Date
+49.71%
1 Year
+79.09%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-17Key Insights
The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Hold
Current Rating
22.667
Target Price
-4.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
ProAssurance Corporation is a specialty insurer with expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 52.74M.%!(EXTRA int=2)
Overvalued
The company’s latest PE is 25.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.60M shares, decreasing 9.60% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 5.56M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
ProAssurance Corporation is a specialty insurer with expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.
Ticker SymbolPRA
CompanyProAssurance Corp
CEOMr. Edward Lewis (Ned) Rand, Jr.
Websitehttps://www.proassurance.com/
Related Instruments
-0.40%
+1.19%
+4.73%
+1.52%
+1.27%
-0.05%
+1.05%
+0.67%
+0.50%
+0.27%
+1.06%
+0.64%
+1.52%
-0.70%
+0.40%
+0.96%
+2.12%
+3.37%
+0.52%
+0.74%
